Abstract |
The genetic characterization of a foscarnet-resistant strain of varicella-zoster virus (VZV) that was isolated from a patient with AIDS is reported. Compared with the sequence of the Dumas reference strain, this strain, which was isolated from a patient in whom foscarnet treatment failed, had two point mutations. The emergence of one of the mutations, which includes a change from a glutamic acid to a lysine at position 512 in the DNA polymerase, suggests that this mutation is implicated in the VZV foscarnet resistance. The other mutation, which replaces serine 863 by a glycine, is also present in 2 susceptible strains--Oka and a wild-type isolate.
|
Authors | B Visse, B Dumont, J M Huraux, A M Fillet |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 178 Suppl 1
Pg. S55-7
(Nov 1998)
ISSN: 0022-1899 [Print] United States |
PMID | 9852975
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antiviral Agents
- DNA Primers
- Foscarnet
- DNA-Directed DNA Polymerase
|
Topics |
- AIDS-Related Opportunistic Infections
(virology)
- Adult
- Amino Acid Sequence
- Amino Acid Substitution
- Antiviral Agents
(pharmacology)
- Base Sequence
- DNA Primers
(genetics)
- DNA-Directed DNA Polymerase
(genetics)
- Drug Resistance, Microbial
(genetics)
- Foscarnet
(pharmacology)
- Herpes Zoster
(complications, virology)
- Herpesvirus 3, Human
(drug effects, enzymology, genetics)
- Humans
- Molecular Sequence Data
- Point Mutation
- Polymerase Chain Reaction
- Sequence Homology, Amino Acid
|